#ZydusLife gets final US FDA nod for Diclofenac Sodium & Misoprostol delayed release tablets

👉 Alert: Diclofenac is used as an anti-inflammatory drug

👉 Alert: Misoprostol helps reduce stomach acidity

#ZydusLife gets #USFDA nod for Minocycline Hydrochloride Extended-release tables USP, 55 mg, 65 mg, and 115 mg, which is used to treat #acne

#USFDA issues 10 observations for #ZydusLife’s injectable manufacturing site in Vadodara. The inspection was conducted from April 15 to April 23, 2024

#ZydusLife signs exclusive licensing & supply agreement with MSN for Cabozantinib tablets for US market

💊Cabozantinib tablets are used alone to treat Advanced
Kidney Cancer

#ZydusLife gets tentative approval from US FDA for Azilsartan Medoxomil tablets

Alert | Azilsartan Medoxomil tablets are used to treat high blood pressure

#ZYDUSLIFE in non-exclusive patent licensing agmt with Takeda for Vonoprazan in India

Vonoprazan is a gastrointestinal drug used to treat gastro duodenal ulcer & GERD

💊#ZydusLife gets Mexico regulator nod to market Bevacizumab Biosimilar in Mexico

🚨Bevacizumab biosimilar is used to treat various types of Cancer

GST Council Likely To Give Relief On A Slew Of Cancer Drugs: Sources to TimsyJaipuria

📌Tax on Trastuzumab Deruxtecan, Osimertinib & Durvalumab can be cut to 5% from 12%
📌Fitment panel’s recommendations based on proposal shared by Health Ministry

📌Alert: Manufacturers of these #CancerDrugs are #Abbott, #ZydusLife, #Alkem, #RelianceLife, #Cipla, #Mylan & #Biocon
📌Alert: 54th #GSTCouncil to meet on September 9 in Delhi

#ZydusLife to develop #Osteoporosis Drug with #CSIR-Central Drug Research Institute Lucknow

#JustIn | #ZydusLife receives tentative approval from USFDA for Enzalutamide Tablets

Alert | Enzalutamide tablets are androgen receptor inhibitors indicated for the treatment of patients with castration-resistant prostate cancer & metastatic castration-sensitive prostate cancer